JP Morgan reduced its stake in INNOVENT BIO (01801) by approximately 15,536,100 shares, with an average price of around HK$43.05 per share.
On September 11, Xiaomi reduced its holdings in Sino Biopharmaceutical (01801) by 15,536,147 shares, with a price of HK$43.0477 per share, totaling approximately HK$669 million.
According to the latest data from the Hong Kong Stock Exchange, on September 11, JP Morgan reduced its holdings of INNOVENT BIO (01801) by 15,536,147 shares, at a price of 43.0477 Hong Kong dollars per share, for a total amount of approximately 669 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 87,805,600 shares, with a latest shareholding percentage of 5.38%.
Related Articles
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
